ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Hemab Therapeutics Holdings, Inc.
34.00
+16.00
88.89%
盘后:
33.10
-0.9000
-2.65%
19:59 EDT
成交量:
411.35万
成交额:
1.29亿
市值:
13.33亿
市盈率:
- -
高:
36.61
开:
27.00
低:
27.00
收:
18.00
52周最高:
36.61
52周最低:
27.00
股本:
3,920.76万
流通股本:
1,176.47万
量比:
- -
换手率:
34.96%
股息:
- -
股息率:
- -
净资产收益率:
-46.99%
总资产收益率:
-30.11%
市净率:
-7.55
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
诺和诺德基金会参投的生物科技公司Hemab(COAG.US)拟赴美IPO,最高募资2.12亿美元
智通财经
·
04/28
Hemab Therapeutics Holdings Inc提交SEC文件:预计IPO股价区间为16-18美元
美股速递
·
04/27
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/COAG/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COAG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","market":"US","secType":"STK","nameCN":"Hemab Therapeutics Holdings, Inc.","latestPrice":34,"timestamp":1777665600000,"preClose":18,"halted":0,"volume":4113516,"hourTrading":{"tag":"盘后","latestPrice":33.1,"preClose":34,"latestTime":"19:59 EDT","volume":24517,"amount":807452.3188,"timestamp":1777679985243,"change":-0.9,"changeRate":-0.026471,"amplitude":0.054412},"delay":0,"changeRate":0.8888888888888888,"floatShares":11764706,"shares":39207616,"eps":0,"marketStatus":"休市中","change":16,"latestTime":"05-01 16:00:00 EDT","open":27,"high":36.61,"low":27,"amount":128926048.828896,"amplitude":0.533889,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":7,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":18,"postHourTrading":{"tag":"盘后","latestPrice":33.1,"preClose":34,"latestTime":"19:59 EDT","volume":24517,"amount":807452.3188,"timestamp":1777679985243,"change":-0.9,"changeRate":-0.026471,"amplitude":0.054412},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","floatShares":11764706,"roa":"-30.11%","roe":"-46.99%","lyrEps":0,"shares":39207616,"dividePrice":0,"high":36.61,"amplitude":0.533889,"preClose":18,"low":27,"week52Low":27,"pbRate":"-7.55","week52High":36.61,"institutionHeld":0,"latestPrice":34,"eps":0,"divideRate":0,"volume":4113516,"delay":0,"ttmEps":0,"open":27,"prevYearClose":18,"prevWeekClose":18,"prevMonthClose":18,"prevQuarterClose":18,"fiveDayClose":18,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COAG\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COAG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COAG\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COAG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COAG","date":"2026-05-01","current":-11.042152,"percent":1,"low":-11.042152,"twenty":-11.042152,"median":-11.042152,"eighty":-11.042152,"high":-11.042152,"avg":-11.042152,"sd":0,"marketCap":705737088},"quantilePoints":[{"date":"2026-05-01","current":-11.042152,"twenty":-11.042152,"median":-11.042152,"eighty":-11.042152,"marketCap":705737088}],"updateTime":1777824676343},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COAG\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630437375","title":"诺和诺德基金会参投的生物科技公司Hemab(COAG.US)拟赴美IPO,最高募资2.12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630437375","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630437375?lang=zh_cn&edition=fundamental","pubTime":"2026-04-28 16:00","pubTimestamp":1777363239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,临床阶段生物科技公司Hemab Therapeutics Holdings Inc.正寻求在美国首次公开募股中最高融资2.12亿美元。此次生物科技公司IPO的背景是,投资者对减肥药物开发商Kailera Therapeutics Inc.给予了热烈反响——该公司于本月初上市,募资7.19亿美元,创下2021年以来该行业在美国最大的IPO记录。招股文件还显示,在本次发行前,RA Capital Management的关联实体与诺和诺德基金会分别持有Hemab 18%和15%的股份。截至2025年12月31日,公司持有现金及现金等价物共1.85亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU1093756168.USD","COAG","BK4581","BK4532","LU0154236417.USD","BK4599","BK4585","NVOX","IE00BKVL7J92.USD","LU1093756325.SGD","NVOH","IE00BZ1G4Q59.USD","NVO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195572245","title":"Hemab Therapeutics Holdings Inc提交SEC文件:预计IPO股价区间为16-18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195572245","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195572245?lang=zh_cn&edition=fundamental","pubTime":"2026-04-27 19:22","pubTimestamp":1777288965,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会(SEC)的文件显示,生物制药公司Hemab Therapeutics Holdings Inc首次公开募股(IPO)的初步定价区间已确定为每股16美元至18美元。\n这一价格区间标志着该公司正式迈出登陆公开资本市场的关键一步。若按此区间上限计算,此次IPO有望为Hemab Therapeutics募集可观的资金,用于推进其创新疗法的研发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}